twincretin tirzepatide (Mounjaro) is a game-changing, once-weekly injection that helps control blood sugar and supports significant weight loss., ๐น Dual Action โ Activates both GIP & GLP-1 receptors for enhanced Understanding Tirzepatide: The Dual-Action Breakthrough
Description
Cabe sealar que PHYSIOMANCE GLP-1 Protect no sustituye en modo alguno al tratamiento con agonistas del GLP-1 y GIP
Facing the GLP-1 Plateau

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors
If a patient isn't losing weight on Zepbound 5mg once weekly, consider discontinuing the medication if they have not lost at least 4% of their baseline body ...

Lowers blood sugar levels

Bromelain and DigeZyme multi-enzyme complex help break down the smaller meals that GLP-1 users typically eat because when you're eating 2030% less food, your body still needs to extract maximum nutrition from what goes in.*
